Sage Analytics Hires Dr. Jason Lupoi as Senior Application Scientist
News Feb 04, 2015
Sage Analytics have hired Jason S. Lupoi, Ph.D. as the company's new Senior Application Scientist.
Dr. Lupoi will be assisting in the development of Sage Analytics' next-generation cannabis potency testing systems featuring advanced optical spectroscopy technology.
Dr. Lupoi received his B.S. degree from La Roche College in Pittsburgh, Pennsylvania, where he graduated summa cum laude, and received the Society of Analytical Chemists of Pittsburgh College Chemistry Award, and achieved his Doctorate in Chemistry from Iowa State University, where he was honored with both a Carver Fellowship and a GAANN Fellowship Award.
He most recently worked at the National Renewable Energy Laboratory in Golden, Colorado and for the Queensland Alliance for Agriculture and Food Innovation where he developed applications of near-infrared, mid-infrared and Raman spectroscopy for the analysis of plants. He has extensive expertise in spectroscopy, and has authored several widely accessed articles encompassing the use of high-throughput analytical spectroscopy as a means for evaluating large data sets of biomass samples.
"We are fortunate to have a leading chemical and spectroscopic scientist on our team," said Matt Kaplan, President of Sage Analytics. "Dr. Lupoi's vast knowledge and thirst for discovery will help keep our company at the forefront of this industry – with a portfolio of superior products that are unmatched in accuracy, reliability and consistency."
Compact Chemical Sensor Can Detect Substances from Over 100 Feet AwayNews
A chemical sensor prototype developed at the University of Michigan will be able to detect "single-fingerprint quantities" of substances from a distance of more than 100 feet away, and its developers are working to shrink it to the size of a shoe box. The development offers great potential for medical and law enforcement purposes.READ MORE
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE